MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 9.556
AS - Asia 4.577
EU - Europa 2.188
SA - Sud America 690
AF - Africa 84
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.114
Nazione #
US - Stati Uniti d'America 9.387
SG - Singapore 1.699
CN - Cina 1.195
BR - Brasile 548
UA - Ucraina 520
VN - Vietnam 463
HK - Hong Kong 400
DE - Germania 366
TR - Turchia 358
GB - Regno Unito 297
IT - Italia 177
PL - Polonia 163
FR - Francia 161
FI - Finlandia 151
SE - Svezia 123
RU - Federazione Russa 94
JP - Giappone 92
MX - Messico 83
IN - India 77
CA - Canada 59
BD - Bangladesh 53
AR - Argentina 45
ZA - Sudafrica 39
ID - Indonesia 38
BE - Belgio 34
IQ - Iraq 34
CO - Colombia 27
NL - Olanda 26
PK - Pakistan 25
ES - Italia 22
CL - Cile 20
UZ - Uzbekistan 17
EC - Ecuador 16
AU - Australia 14
MY - Malesia 14
VE - Venezuela 14
PH - Filippine 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 10
IR - Iran 10
LT - Lituania 10
MA - Marocco 10
JM - Giamaica 9
JO - Giordania 9
NP - Nepal 8
KR - Corea 7
RO - Romania 7
TN - Tunisia 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PE - Perù 6
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AT - Austria 4
CH - Svizzera 4
EG - Egitto 4
KG - Kirghizistan 4
TW - Taiwan 4
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GM - Gambi 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 17.100
Città #
Singapore 1.084
Ashburn 998
Woodbridge 897
Fairfield 876
Houston 585
Jacksonville 565
San Jose 549
Ann Arbor 502
Chandler 433
Hong Kong 392
Santa Clara 392
Beijing 375
Seattle 336
Wilmington 310
Dallas 301
Cambridge 252
Izmir 174
Nanjing 170
Ho Chi Minh City 163
Warsaw 158
Dearborn 127
Los Angeles 124
Hanoi 121
Princeton 107
San Diego 104
Lauterbourg 90
Tokyo 90
New York 82
Boardman 74
Addison 68
São Paulo 67
Mexico City 58
Milan 53
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Shanghai 38
Ferrara 37
Brooklyn 36
Council Bluffs 35
Hebei 35
Brussels 34
Helsinki 30
Jiaxing 29
London 29
Washington 28
Chicago 27
Da Nang 27
Tianjin 27
Jinan 23
San Mateo 23
Buffalo 22
Falkenstein 22
San Francisco 22
Auburn Hills 21
Phoenix 21
Porto Alegre 21
Rio de Janeiro 21
Turku 21
Bremen 19
Changsha 19
Haiphong 19
Orem 19
Baghdad 18
Frankfurt am Main 18
Johannesburg 18
Kunming 18
Mountain View 16
Toronto 16
Zhengzhou 16
Boston 15
Chennai 15
Jakarta 15
Montreal 15
Moscow 15
Stockholm 15
Manchester 14
Poplar 13
Tashkent 13
Denver 12
Falls Church 12
Guangzhou 12
Norwalk 12
Atlanta 11
Ningbo 11
Amsterdam 10
Belo Horizonte 10
Brasília 10
Dong Ket 10
Hải Dương 10
Philadelphia 10
The Dalles 10
Columbus 9
Des Moines 9
Indiana 9
Redwood City 9
Dhaka 8
Istanbul 8
Lahore 8
Totale 12.019
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 407
A cyclic peptide T analogue with high chemotactic activity 287
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 259
Arecoline tripeptide inhibitors of proteasome 247
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 244
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 224
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 223
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 221
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 217
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 215
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 215
Vinyl ester-based cyclic peptide proteasome inhibitors 214
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 209
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 205
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 204
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 204
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 203
A Bioactive Fullerene Peptide 202
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 202
A 500 MHz study of peptide T in a DMSO solution 200
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 195
Conformational analysis of peptide T and of its C‐pentapeptide fragment 195
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 191
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 190
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 190
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 189
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 188
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 185
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 183
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 182
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 180
Structure–activity relationships of cyclic and linear peptide T analogues 179
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 178
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 175
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 175
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 173
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 173
Synthesis and biological activity of carboxyl terminally extended dermorphins 173
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 172
Anodic mineralization of pentachlorophenol in alkaline media 170
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 167
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 167
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 164
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 162
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 160
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 158
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 157
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 157
Conformational properties of deltorphin: new features of the delta-opioid receptors 155
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 154
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 153
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 152
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 152
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 152
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 152
New cyclic peptide proteasome inhibitors 151
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 150
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 149
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 146
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 146
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 143
Synthesis and structure activity relationships of delthorphine analogues 142
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 142
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 142
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 141
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 140
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 139
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 137
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 132
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 131
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 130
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 128
Opioid peptides. Partially modified retro-inverso dermorphin analogues 128
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 128
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 125
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 124
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 124
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 123
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 123
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 123
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 121
Peptide-based molecules for the production of positive charged liposomes and micelles 119
Synthesis and activity of new linear and cyclic peptide T derivatives 118
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 118
Synthesis and biological activity of chelator-peptide T conjugates 117
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 117
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 115
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 114
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 110
Structure-activity relationships of peptide T-related pentapeptides 109
null 107
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 107
null 107
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 106
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TO PENTAPEPTIDE ANALOG DERIVED FROM IMMUNODEFICIENCY VIRUS PROTEIN gp120 106
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 104
Synthesis and antiaggregatory activity of antiflammin related peptides 99
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 99
null 96
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 95
Totale 16.171
Categoria #
all - tutte 73.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.238
Totale 74.887


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/20221.267 44 91 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20265.934 652 290 733 745 772 363 649 278 537 708 191 16
Totale 17.219